Oury, C.; Maréchal, P.; Donis, N.; Hulin, A.; Hego, A.; Tridetti, J.; Nguyen, M.-L.; Dulgheru, R.; Fillet, M.; Nchimi, A.;
et al. Dexfenfluramine and Pergolide Cause Heart Valve Disease via Valve Metabolic Reprogramming and Ongoing Matrix Remodeling. Int. J. Mol. Sci. 2020, 21, 4003.
https://doi.org/10.3390/ijms21114003
AMA Style
Oury C, Maréchal P, Donis N, Hulin A, Hego A, Tridetti J, Nguyen M-L, Dulgheru R, Fillet M, Nchimi A,
et al. Dexfenfluramine and Pergolide Cause Heart Valve Disease via Valve Metabolic Reprogramming and Ongoing Matrix Remodeling. International Journal of Molecular Sciences. 2020; 21(11):4003.
https://doi.org/10.3390/ijms21114003
Chicago/Turabian Style
Oury, Cécile, Patrick Maréchal, Nathalie Donis, Alexia Hulin, Alexandre Hego, Julien Tridetti, Mai-Linh Nguyen, Raluca Dulgheru, Marianne Fillet, Alain Nchimi,
and et al. 2020. "Dexfenfluramine and Pergolide Cause Heart Valve Disease via Valve Metabolic Reprogramming and Ongoing Matrix Remodeling" International Journal of Molecular Sciences 21, no. 11: 4003.
https://doi.org/10.3390/ijms21114003
APA Style
Oury, C., Maréchal, P., Donis, N., Hulin, A., Hego, A., Tridetti, J., Nguyen, M. -L., Dulgheru, R., Fillet, M., Nchimi, A., & Lancellotti, P.
(2020). Dexfenfluramine and Pergolide Cause Heart Valve Disease via Valve Metabolic Reprogramming and Ongoing Matrix Remodeling. International Journal of Molecular Sciences, 21(11), 4003.
https://doi.org/10.3390/ijms21114003